Populations with essential hypertension have a high risk of nonalcoholic steatohepatitis (NASH). In this study, we investigated the mechanism that underlies the progression of hypertension-associated NASH by comparing differences in the development of high fat and cholesterol (HFC) diet-induced NASH among three strains of rats, i.e., two hypertensive strains comprising spontaneously hypertensive rats and the stroke-prone spontaneously hypertensive 5/Dmcr, and the original Wistar Kyoto rats as the normotensive control. We investigated histopathological changes and molecular signals related to inflammation in the liver after feeding with the HFC diet for 8 weeks. The diet induced severe lobular inflammation and fibrosis in the livers of the h...
Cardiovascular disease (CVD) is the leading cause of death among non-communicable diseases. There is...
<div><p>Nonalcoholic steatohepatitis is related to lifestyle, particularly to dietary habits. We dev...
Background: Recently, we established a novel rodent model of nonalcoholic steatohepatitis (NASH) wit...
Systemic hypertension, characterized by elevated blood pressure ≥140/90 mm Hg, is a major modifiable...
Nonalcoholic steatohepatitis (NASH) involves liver lipid accumulation (steatosis) combined with hepa...
Abstract: The hypertension is one of chronic vascular diseases, which often implicates multiple tiss...
CVD (cardiovascular disease) is associated with abnormal liver enzymes, and NAFLD (non-alcoholic fat...
BACKGROUND: Nonalcoholic steatohepatitis (NASH) develops in the absence of chronic and excessive alc...
Non-alcoholic fatty liver disease (NAFLD) is gaining in importance and is linked to obesity. Especi...
The nature of the chronic inflammatory component that drives the development of non-alcoholic steato...
High-dietary fat intake is a major risk factor for development of metabolic and cardiovascular-renal...
Non-alcoholic fatty liver disease (NAFLD) is gaining in importance and is linked to obesity. Especia...
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Mo...
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Mo...
International audienceInflammation and oxidative stress are thought to be involved in, or associated...
Cardiovascular disease (CVD) is the leading cause of death among non-communicable diseases. There is...
<div><p>Nonalcoholic steatohepatitis is related to lifestyle, particularly to dietary habits. We dev...
Background: Recently, we established a novel rodent model of nonalcoholic steatohepatitis (NASH) wit...
Systemic hypertension, characterized by elevated blood pressure ≥140/90 mm Hg, is a major modifiable...
Nonalcoholic steatohepatitis (NASH) involves liver lipid accumulation (steatosis) combined with hepa...
Abstract: The hypertension is one of chronic vascular diseases, which often implicates multiple tiss...
CVD (cardiovascular disease) is associated with abnormal liver enzymes, and NAFLD (non-alcoholic fat...
BACKGROUND: Nonalcoholic steatohepatitis (NASH) develops in the absence of chronic and excessive alc...
Non-alcoholic fatty liver disease (NAFLD) is gaining in importance and is linked to obesity. Especi...
The nature of the chronic inflammatory component that drives the development of non-alcoholic steato...
High-dietary fat intake is a major risk factor for development of metabolic and cardiovascular-renal...
Non-alcoholic fatty liver disease (NAFLD) is gaining in importance and is linked to obesity. Especia...
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Mo...
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Mo...
International audienceInflammation and oxidative stress are thought to be involved in, or associated...
Cardiovascular disease (CVD) is the leading cause of death among non-communicable diseases. There is...
<div><p>Nonalcoholic steatohepatitis is related to lifestyle, particularly to dietary habits. We dev...
Background: Recently, we established a novel rodent model of nonalcoholic steatohepatitis (NASH) wit...